Implications for pharmaceutical companies and clinicians from the Bayer v NHS judgement: an increasing budgetary focus for both – (Implications for pharmaceutical companies and clinicians from the Bayer v NHS judgement: an increasing budgetary focus for both, Published online: 2018-11-29; | doi:10.1038/s41433-018-0280-3)

29 November 2018

This news item is available to RCOphth members only, please log in below to access.